FOR IMMEDIATE RELEASE
Wise Therapeutics Pursues FDA Clearance for Gamified Prescription Digital Therapeutics Targeting Three Initial Indications
Unmet need, health economic and outcomes impact to be evaluated in advance of lead candidate selection
(March 30, 2021, NEW YORK) Wise Therapeutics (Wise), a developer of game-based digital therapeutics such as the mental wellness product Personal Zen, has today announced its intention to pursue FDA clearance across three target indications; alcohol use disorder, multiple sclerosis-related anxiety, and perinatal anxiety. This decision follows the success of three clinical trials which demonstrated the efficacy and impact of Wise’s core attention bias modification (ABM) engine across these indications.
“We are encouraged that all three proof-of-concept trials demonstrated our ABM technology’s robust efficacy across biometric and behavioral endpoints,” said Dr. Tracy Dennis-Tiwary, Co-founder and Co-CEO of Wise Therapeutics. “We plan on iterating and further personalizing our products in order to optimize for both efficacy and engagement in these populations before beginning pilot trials.”
Topline results from the three clinical trials included:
Wise will evaluate their ABM technology’s potential impact on unmet need, health economics and outcomes across target indications in advance of selecting their lead candidate.
“The COVID-19 crisis has brought to the surface the dire need for accessible, effective mental health treatments, and we have seen growing institutional enthusiasm for this emerging category of medicine as a result,” said Nayan Ghosh, Commercial Strategy Lead, who recently joined Wise from Marwood Group where he consulted on pipeline and market access strategy for prescription DTx developers. “Wise has always prioritized a robust evidence base, and we are excited to leverage and build on that in order to help vulnerable patient populations in need of accessible treatments.”
ABOUT WISE THERAPEUTICS INC.:
Wise Therapeutics combines cognitive therapy with clinical neuroscience to develop gamified, clinically validated digital therapeutics that address pervasive behavioral health challenges. Over 60 million Americans suffer from mental health problems annually, and over half of us (150 million people) will experience a clinically debilitating mental health problem in our lifetime. Among this group, many of whom suffer from stress, anxiety, depression, and addiction, 50% never seek treatment. Low access, high price, and stigma are the leading barriers to accessing treatment. Wise Therapeutics’ mission is to have a powerful, positive impact on the global mental and behavioral health crisis through the translation of clinical neuroscience into digital therapies that lower barriers to access and are as engaging as they are clinically effective.
Learn more about Wise Therapeutics at www.wisedtx.com.
**END**
***END***
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Cookie | Duration | Description |
---|---|---|
_gauges_cookie | past | This cookie is set by Gauges. This cookie helps in improving the webisite by tracking the user behaviour on using the website. |
_gauges_unique | 1 year | This cookie is set by Gauges. This cookies used for various purposes like proper functioning of the service, marketing and statistical analysis needed for the website. It helps to improve the website by collecting information of the visitors behaviour. |
_gauges_unique_day | 1 day | These cookie is set by Gauges for various purposes including ensuring proper functioning our Services, marketing and other statistical analyses needed by the website. |
_gauges_unique_hour | 1 hour | This cookie is set by Gauges. This cookie is used for various purposes like proper functioning of the service, marketing and statistical analysis needed for the website. |
_gauges_unique_month | 1 month | This cookie are set by Gauges, this is Performance type cookies. They collect information about how visitors use the website and improves the website with this information.This cookie is used for various purposes like proper functioning of the service, marketing and statistical analysis needed for the website. |
_gauges_unique_year | 1 year | This cookie is set by Gauges. This cookies used for various purposes like proper functioning of the service, marketing and statistical analysis needed for the website. |
Cookie | Duration | Description |
---|---|---|
_ga | 2 years | The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors. |
_gat_gtag_UA_159831098_1 | 1 minute | Set by Google to distinguish users. |
_gid | 1 day | Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously. |